OptimizeRx(OPRX) - 2025 Q4 - Annual Results

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Q4 revenue of $32.2 million WALTHAM, MA. – March 5, 2026 – OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the fourth quarter and full year ended December 31, 2025. Financial Highlights Stephen L. Silvestro, OptimizeRx CEO commented, "We delivered a stro ...